UHS Earnings Reports

Universal Health Services, Inc. reported Q4 2024 revenue of $4.11 billion, an increase of 11.1% year-over-year. Net income rose to $332.4 million, while adjusted EPS increased to $4.92. Revenue from acute care and behavioral health services grew by 8.7% and 11.1%, respectively. EBITDA net of NCI improved to $620.2 million, reflecting strong operational performance.

Universal Health Services, Inc. reported strong Q3 2024 results, with net revenues increasing by 11.2% to $3.963 billion and net income attributable to UHS reaching $258.7 million, or $3.80 per diluted share, compared to $167.0 million, or $2.40 per diluted share, in Q3 2023. Adjusted net income was $252.5 million, or $3.71 per diluted share. EBITDA net of NCI was $528.6 million, representing 13.3% of net revenues.

Universal Health Services, Inc. reported a strong second quarter in 2024, with net income attributable to UHS of $289.2 million, or $4.26 per diluted share, compared to $171.3 million, or $2.42 per diluted share, in the second quarter of 2023. Net revenues increased by 10.1% to $3.908 billion. The company also increased its full-year operating results forecast and announced a $1 billion increase to its stock repurchase program authorization.

Universal Health Services, Inc. reported a strong first quarter in 2024, with net income attributable to UHS reaching $261.8 million, or $3.82 per diluted share, compared to $163.1 million, or $2.28 per diluted share, in the first quarter of 2023. Net revenues also saw a substantial increase of 10.8% to $3.844 billion.

Universal Health Services, Inc. reported a net income attributable to UHS of $216.4 million, or $3.16 per diluted share, for the fourth quarter of 2023, compared to $174.8 million, or $2.43 per diluted share, for the fourth quarter of 2022. Net revenues increased by 7.4% to $3.704 billion during the fourth quarter of 2023, as compared to $3.447 billion during the fourth quarter of 2022.

Universal Health Services, Inc. reported a net income attributable to UHS of $167.0 million, or $2.40 per diluted share, for Q3 2023, compared to $182.8 million, or $2.50 per diluted share, for Q3 2022. Net revenues increased by 6.8% to $3.563 billion. Adjusted net income attributable to UHS was $177.5 million, or $2.55 per diluted share, compared to $185.8 million, or $2.54 per diluted share, for the same period last year.

Universal Health Services, Inc. reported a 6.8% increase in net revenues, reaching $3.548 billion in Q2 2023. Net income attributable to UHS was $171.3 million, or $2.42 per diluted share, compared to $164.1 million, or $2.20 per diluted share, in Q2 2022. Adjusted net income was $179.4 million, or $2.53 per diluted share.

Universal Health Services, Inc. reported a rise in net income attributable to UHS to $163.1 million, or $2.28 per diluted share, in Q1 2023, compared to $153.9 million, or $2.02 per diluted share, in Q1 2022. Net revenues also saw an increase of 5.3% to $3.468 billion during the same period.

Universal Health Services, Inc. reported a 5.2% increase in net revenues to $3.447 billion for the fourth quarter of 2022, compared to $3.275 billion in the fourth quarter of 2021. However, net income attributable to UHS decreased to $174.8 million, or $2.43 per diluted share, from $239.1 million, or $3.00 per diluted share, in the same period of the previous year. Adjusted net income attributable to UHS was $217.1 million, or $3.02 per diluted share, compared to $235.1 million, or $2.95 per diluted share, for the fourth quarter of 2021.

Universal Health Services, Inc. reported a decrease in net income attributable to UHS to $182.8 million, or $2.50 per diluted share, during the third quarter of 2022, compared to $218.4 million, or $2.60 per diluted share, during the third quarter of 2021. Net revenues increased by 5.7% to $3.336 billion during the third quarter of 2022 as compared to $3.156 billion during the third quarter of 2021.